Arcus Biosciences (RCUS) Short Interest
NYSE • RCUS • US03969F1093
As of Oct 29, 2026, ORTEX estimated 11.5% of free float sold short, 4.8 days to cover, cost to borrow 0.49%. Sign up for live short interest data.
NYSE • RCUS • US03969F1093
As of Oct 29, 2026, ORTEX estimated 11.5% of free float sold short, 4.8 days to cover, cost to borrow 0.49%. Sign up for live short interest data.
This page tracks how heavily Arcus Biosciences (NYSE:RCUS) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Arcus Biosciences (NYSE: RCUS) has a market capitalization of $2.51B. Last close $17.43 (as of 2026-11-16); 52-week range $17.03 to $31.74. ORTEX data as of 2026-10-29: short interest was 11.49% of free float, 4.8 days to cover and the average cost to borrow was 0.49%. Sign up for live short interest data.